Literature DB >> 16674942

Differential expression of retinal pigment epithelium (RPE) IP-10 and interleukin-8.

Susan G Elner1, Derek Delmonte, Zong-Mei Bian, Nicholas W Lukacs, Victor M Elner.   

Abstract

Interferon-gamma induced protein of 10 kDa (IP-10) is a C-X-C chemokine that attracts T lymphocytes and inhibits angiogenesis. In this study, we investigated the expression of IP-10 by human retinal pigment epithelial cells (HRPE) and compared IP-10 expression to that of interleukin-8 (IL-8), which is a leukocytic chemoattractant and pro-angiogenic factor. Cultured HRPE cells were incubated with either IL-1 beta (0.2-20 ng/ml) or tumor necrosis factor (TNF)-alpha (0.2-20 ng/ml) alone or in combination with interferon-gamma (IFN-gamma) (1000 U/ml). HRPE cells were also incubated with: (1) media conditioned by activated human T lymphocytes (CM), or (2) the same CM treated with neutralizing antibodies to IL-1, TNF, and/or IFN-gamma. IL-8 and IP-10 protein levels were measured by ELISA and mRNA levels by Northern blot analysis of HRPE cells. HRPE cells produced very high levels of IP-10 in response to either IL-1 beta/IFN-gamma, TNF-alpha/IFN-gamma or CD3-activated T-lymphocyte CM. The levels of IP-10 were at least tenfold higher (p<.001) than IL-8 measured in the same samples. Neutralizing antibodies to TNF and IFN-gamma, but not to IL-1, abrogated the ability of the CD3-activated T lymphocytes CM to induce HRPE IP-10 (p<.001). HRPE cells produce differential levels of IP-10 and IL-8 in response to various combinations of recombinant and T-lymphocyte-secreted pro-inflammatory cytokines. This may be important in evolving inflammatory and angiogenic ocular responses.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16674942     DOI: 10.1016/j.exer.2006.01.013

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  9 in total

1.  Control of chemokine gradients by the retinal pigment epithelium.

Authors:  Guangpu Shi; Arvydas Maminishkis; Tina Banzon; Stephen Jalickee; Rong Li; Jeffrey Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

2.  Pro-angiogenic effect of IFNgamma is dependent on the PI3K/mTOR/translational pathway in human retinal pigmented epithelial cells.

Authors:  Baoying Liu; Lisa Faia; Mengjun Hu; Robert B Nussenblatt
Journal:  Mol Vis       Date:  2010-02-10       Impact factor: 2.367

3.  Microarray analysis of gene expression in West Nile virus-infected human retinal pigment epithelium.

Authors:  Luis Munoz-Erazo; Ricardo Natoli; Jan Marie Provis; Michelle Catherine Madigan; Nicholas Jonathan Cole King
Journal:  Mol Vis       Date:  2012-03-27       Impact factor: 2.367

4.  Chemokine-mediated inflammation in the degenerating retina is coordinated by Müller cells, activated microglia, and retinal pigment epithelium.

Authors:  Matt Rutar; Riccardo Natoli; R X Chia; Krisztina Valter; Jan M Provis
Journal:  J Neuroinflammation       Date:  2015-01-17       Impact factor: 8.322

5.  Proinflammatory cytokines decrease the expression of genes critical for RPE function.

Authors:  R Krishnan Kutty; William Samuel; Kaifa Boyce; Aswini Cherukuri; Todd Duncan; Cynthia Jaworski; Chandrasekharam N Nagineni; T Michael Redmond
Journal:  Mol Vis       Date:  2016-10-08       Impact factor: 2.367

Review 6.  Scaffolds for retinal pigment epithelial cell transplantation in age-related macular degeneration.

Authors:  Corina E White; Ronke M Olabisi
Journal:  J Tissue Eng       Date:  2017-07-21       Impact factor: 7.813

7.  Expression of IP-10 related to angiogenesis in uterine cervical cancers.

Authors:  E Sato; J Fujimoto; H Toyoki; H Sakaguchi; S M Alam; I Jahan; T Tamaya
Journal:  Br J Cancer       Date:  2007-05-15       Impact factor: 7.640

Review 8.  Mechanisms of leukocyte migration across the blood-retina barrier.

Authors:  Isabel J Crane; Janet Liversidge
Journal:  Semin Immunopathol       Date:  2008-02-28       Impact factor: 9.623

9.  Aqueous humour cytokines profiles in eyes with Coats disease and the association with the severity of the disease.

Authors:  Tingyi Liang; Yu Xu; Xiuyu Zhu; Xiang Zhang; Jing Li; Peiquan Zhao
Journal:  BMC Ophthalmol       Date:  2020-05-05       Impact factor: 2.209

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.